AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/126
ONCOSTRESS - EVALUATION OF BURNOUT IN LOMBARDY
Authors: BARNI S MONDIN R NAZZANI R ARCHILI C
Citation: S. Barni et al., ONCOSTRESS - EVALUATION OF BURNOUT IN LOMBARDY, Tumori, 82(1), 1996, pp. 85-92
BIOLOGICAL SIGNIFICANCE OF INTERLEUKIN-6 SECRETION ON CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2
Authors: LISSONI P FUMAGALLI L BARNI S DIFELICE G ARDIZZOIA A MAIORCA F TANCINI G
Citation: P. Lissoni et al., BIOLOGICAL SIGNIFICANCE OF INTERLEUKIN-6 SECRETION ON CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, International journal of immunotherapy, 12(3-4), 1996, pp. 49-52
CELL ACTIVATION AND DEATH (APOPTOSIS) INDUCED BY IL-2 - ULTRASTRUCTURAL EVIDENCE
Authors: CAPELLI E BARNI S VACCARONE R FORTIS C NANO R
Citation: E. Capelli et al., CELL ACTIVATION AND DEATH (APOPTOSIS) INDUCED BY IL-2 - ULTRASTRUCTURAL EVIDENCE, Anticancer research, 16(4A), 1996, pp. 1775-1780
PREOPERATIVE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY MAY PROLONG THESURVIVAL-TIME IN ADVANCED COLORECTAL-CANCER PATIENTS
Authors: BRIVIO F LISSONI P ALDERI G BARNI S LAVORATO F FUMAGALLI L
Citation: F. Brivio et al., PREOPERATIVE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY MAY PROLONG THESURVIVAL-TIME IN ADVANCED COLORECTAL-CANCER PATIENTS, Oncology, 53(4), 1996, pp. 263-268
INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE
Authors: LISSONI P MEREGALLI S NOSETTO L BARNI S TANCINI G FOSSATI V MAESTRONI G
Citation: P. Lissoni et al., INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE, Oncology, 53(1), 1996, pp. 43-46
SPONTANEOUS APOPTOSIS OF THYMOCYTES IS UNCOUPLED WITH PROGRESSION THROUGH THE CELL-CYCLE
Authors: PELLICCIARI C BOTTONE MG SCHAACK V BARNI S MANFREDI AA
Citation: C. Pellicciari et al., SPONTANEOUS APOPTOSIS OF THYMOCYTES IS UNCOUPLED WITH PROGRESSION THROUGH THE CELL-CYCLE, Experimental cell research, 229(2), 1996, pp. 370-377
A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS
Authors: LISSONI P PAOLOROSSI F TANCINI G ARDIZZOIA A BARNI S BRIVIO F MAESTRONI GJM CHILELLI M
Citation: P. Lissoni et al., A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS, British Journal of Cancer, 74(9), 1996, pp. 1466-1468
ORAL ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY FOR COLORECTAL-CANCER - A GISCAD STUDY
Authors: ZANIBONI A LABIANCA R PANCERA G BARNI S FRONTINI L MARINI G LUPORINI G
Citation: A. Zaniboni et al., ORAL ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY FOR COLORECTAL-CANCER - A GISCAD STUDY, Journal of chemotherapy, 7(3), 1995, pp. 246-248
EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS
Authors: LISSONI P ARDIZZOIA A BARNI S BRIVIO F TISI E ROVELLI F TANCINI G MAESTRONI G FUMAGALLI L
Citation: P. Lissoni et al., EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS, Oncology Reports, 2(6), 1995, pp. 1063-1068
A RANDOMIZED STUDY OF TAMOXIFEN ALONE VERSUS TAMOXIFEN PLUS MELATONININ ESTROGEN RECEPTOR-NEGATIVE HEAVILY PRETREATED METASTATIC BREAST-CANCER PATIENTS
Authors: LISSONI P ARDIZZOIA A BARNI S PAOLOROSSI F TANCINI G MEREGALLI S ESPOSTI D ZUBELEWICZ B BRACZOWSKI R
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF TAMOXIFEN ALONE VERSUS TAMOXIFEN PLUS MELATONININ ESTROGEN RECEPTOR-NEGATIVE HEAVILY PRETREATED METASTATIC BREAST-CANCER PATIENTS, Oncology Reports, 2(5), 1995, pp. 871-873
PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA
Authors: BRIVIO F LISSONI P FUMAGALLI L BRIVIO O LAVORATO F RESCALDANI R CONTI A ROSELLI MG MAESTRONI G BARNI S
Citation: F. Brivio et al., PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA, Oncology Reports, 2(4), 1995, pp. 597-599
TREATMENT OF INTERFERON-ALPHA 2A(IFN)-INDUCED THROMBOCYTOPENIA BY THEPINEAL NEUROHORMONE MELATONIN (MTL)
Authors: LISSONI P BARNI S TANCINI G ADIZZOIA A PAOLOROSSI F
Citation: P. Lissoni et al., TREATMENT OF INTERFERON-ALPHA 2A(IFN)-INDUCED THROMBOCYTOPENIA BY THEPINEAL NEUROHORMONE MELATONIN (MTL), European journal of cancer, 31A, 1995, pp. 583-583
DOXIFLURIDINE IN ADVANCED COLORECTAL-CARCINOMA - PARALLEL MULTICENTERRANDOMIZED PHASE-II TRIAL
Authors: DIBARTOLOMEO M SOMMA L BAJETTA E BUZZONI R MORESCHI M CASARETTI R TURCI D GEBBIA V DIMAIUTA MS BORDOGNA G COLLEONI M MANTOVANI G RABBI C BARNI S FERRARI VD MARINI G STAMPINO CG
Citation: M. Dibartolomeo et al., DOXIFLURIDINE IN ADVANCED COLORECTAL-CARCINOMA - PARALLEL MULTICENTERRANDOMIZED PHASE-II TRIAL, European journal of cancer, 31A, 1995, pp. 719-719
L-LEUCOVORIN (LLV) AS A MODULATOR OF 5-DAYS 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL-CANCER (ACC) - HIGH-DOSE (HD) VERSUS MW DOSE (LD)
Authors: LABIANCA R CASCINU S BARNI S FIORENTINI G FRONTINI L COMELLA G ZANIBONI A DALLAVALLE G PANCERA G LUPORINI AC PESSI A LUPORINI G
Citation: R. Labianca et al., L-LEUCOVORIN (LLV) AS A MODULATOR OF 5-DAYS 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL-CANCER (ACC) - HIGH-DOSE (HD) VERSUS MW DOSE (LD), European journal of cancer, 31A, 1995, pp. 735-735
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
A RANDOMIZED STUDY OF NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN COMPARED TO SUPPORTIVE CARE ALONE IN PATIENTS WITH UNTREATABLE METASTATIC SOLID TUMOR
Authors: LISSONI P BARNI S FOSSATI V ARDIZZOIA A CAZZANIGA M TANCINI G FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN COMPARED TO SUPPORTIVE CARE ALONE IN PATIENTS WITH UNTREATABLE METASTATIC SOLID TUMOR, Supportive care in cancer, 3(3), 1995, pp. 194-197
INTRACAVITARY THERAPY OF NEOPLASTIC EFFUSIONS WITH CYTOKINES - COMPARISON AMONG INTERFERON-ALPHA, INTERFERON-BETA AND INTERLEUKIN-2
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A TISI E ANGELI M RIZZI A
Citation: P. Lissoni et al., INTRACAVITARY THERAPY OF NEOPLASTIC EFFUSIONS WITH CYTOKINES - COMPARISON AMONG INTERFERON-ALPHA, INTERFERON-BETA AND INTERLEUKIN-2, Supportive care in cancer, 3(1), 1995, pp. 78-80
POSSIBLE OCCURRENCE OF AMITOTIC CELL-DIVISION DURING HEMATOPOIESIS INTHE URODELES
Authors: BARNI S FRASCHINI A PROSPERI E VACCARONE R BERNINI F
Citation: S. Barni et al., POSSIBLE OCCURRENCE OF AMITOTIC CELL-DIVISION DURING HEMATOPOIESIS INTHE URODELES, Comparative haematology international, 5(3), 1995, pp. 183-188
LYSOSOMAL EXOCYTOSIS INDUCED BY HYPERTHERMIA - A NEW MODEL OF CANCER CELL-DEATH .2. EFFECT ON PERITONEAL-MACROPHAGES
Authors: PONTIGGIA P BARNI S MATHE G BERTONE V PONTIGGIA E
Citation: P. Pontiggia et al., LYSOSOMAL EXOCYTOSIS INDUCED BY HYPERTHERMIA - A NEW MODEL OF CANCER CELL-DEATH .2. EFFECT ON PERITONEAL-MACROPHAGES, Biomedicine & pharmacotherapy, 49(9), 1995, pp. 429-430
RELATION BETWEEN MACROPHAGE AND T-HELPER-2 LYMPHOCYTE FUNCTIONS IN HUMAN NEOPLASMS - NEOPTERIN, INTERLEUKIN-10 AND INTERLEUKIN-6 BLOOD-LEVELS IN EARLY OR ADVANCED SOLID TURNERS
Authors: LISSONI P ROVELLI F TISI E BRIVIO F ARDIZZOIA A BARNI S TANCINI G SAUDELLI M CESANA E VIGANO MG
Citation: P. Lissoni et al., RELATION BETWEEN MACROPHAGE AND T-HELPER-2 LYMPHOCYTE FUNCTIONS IN HUMAN NEOPLASMS - NEOPTERIN, INTERLEUKIN-10 AND INTERLEUKIN-6 BLOOD-LEVELS IN EARLY OR ADVANCED SOLID TURNERS, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 146-149
NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/
Authors: LISSONI P VIGORE L RESCALDANI R ROVELLI F BRIVIO F GIANI L BARNI S TANCINI G ARDIZZOIA A VIGANO MG
Citation: P. Lissoni et al., NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 155-158
TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA BY LOW-DOSE SUBCUTANEOUSINTERLEUKIN-2 PLUS THE PINEAL HORMONE MELATONIN - A BIOLOGICAL PHASE-II STUDY
Authors: LISSONI P BARNI S BRIVIO F ROSSINI F FUMAGALLI L TANCINI G
Citation: P. Lissoni et al., TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA BY LOW-DOSE SUBCUTANEOUSINTERLEUKIN-2 PLUS THE PINEAL HORMONE MELATONIN - A BIOLOGICAL PHASE-II STUDY, Journal of biological regulators and homeostatic agents, 9(2), 1995, pp. 52-54
CORRELATION BETWEEN PRETREATMENT SERUM LEVELS OF NEOPTERIN AND RESPONSE TO INTERLEUKIN-2 IMMUNOTHERAPY IN CANCER-PATIENTS
Authors: LISSONI P BARNI S ARDIZZOIA A SCARDINO E TANCINI G VIGANO MG
Citation: P. Lissoni et al., CORRELATION BETWEEN PRETREATMENT SERUM LEVELS OF NEOPTERIN AND RESPONSE TO INTERLEUKIN-2 IMMUNOTHERAPY IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 9(1), 1995, pp. 21-23
ENDOCRINE EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN CANCER-PATIENTS
Authors: ROVELLI F BARNI S TANCINI G ARDIZZOIA A LISSONI P
Citation: F. Rovelli et al., ENDOCRINE EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN CANCER-PATIENTS, Tumori, 81(6), 1995, pp. 438-439
CLINICAL EFFICACY OF CANCER SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 IN RELATION TO THE PRETREATMENT LEVELS OF TUMOR-GROWTH FACTOR INSULIN-LIKE GROWTH-FACTOR-I
Authors: LISSONI P BARNI S ARDIZZOIA A FRIGERIO F PAOLOROSSI F CAZZANIGA M TANCINI G ROCCO F AAPRO M
Citation: P. Lissoni et al., CLINICAL EFFICACY OF CANCER SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 IN RELATION TO THE PRETREATMENT LEVELS OF TUMOR-GROWTH FACTOR INSULIN-LIKE GROWTH-FACTOR-I, Tumori, 81(4), 1995, pp. 261-264
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>